Am J Med Genet B Neuropsychiatr Genet

1. GAWLIK M, Schneider P, Pfuhlmann B, Deckert J, et al
   Schizophrenic Phenotype and Therapeutic Course Associated With Chromosome 22q11.2 Deletion in a Cohort Without Prior Diagnosis of Chromosome 22q11.2 Deletion Syndrome.
   Am J Med Genet B Neuropsychiatr Genet. 2026 Feb 6. doi: 10.1002/ajmgb.70008.
   

   >> Share

   
   

   
   Am J Psychiatry

2. KAUL I, Claxton A, Sauder C, Patel T, et al
   Long-Term Safety and Efficacy of Xanomeline and Trospium Chloride in Schizophrenia: A 52-Week Open-Label Extension Trial.
   Am J Psychiatry. 2026 Feb 4:appiajp20241186. doi: 10.1176/appi.ajp.20241186.
   

   >> Share

   
   
3. KALIN NH
   Neuroplasticity, Antipsychotic Efficacy, Schizophrenia Risk Reduction With Doxycycline Exposure, and Cannabis and Alcohol Use Interactions.
   Am J Psychiatry. 2026;183:87-89.
   

   >> Share

   
   

   
   Br J Psychiatry

4. KARA VM
   Cultural heritage tourism as an adjunct in schizophrenia.
   Br J Psychiatry. 2026 Feb 5:1-2. doi: 10.1192/bjp.2025.10532.
   

   >> Share

   
   

   
   J Clin Psychopharmacol

5. JOHN AP, Prajapati H, Dragovic M
   Reply to "Beyond Clozapine: Addressing Broader Metabolic Burden in Treatment-Resistant Schizophrenia".
   J Clin Psychopharmacol. 2026 Feb 4. doi: 10.1097/JCP.0000000000002134.
   

   >> Share

   
   

   
   Mol Psychiatry

6. KINJO M, Tamura S, Sugiyama S, van Weert E, et al
   A systematic review and meta-analysis of the auditory steady-state response in schizophrenia, bipolar disorder, and autism spectrum disorder.
   Mol Psychiatry. 2026 Feb 3. doi: 10.1038/s41380-026-03452.
   

   >> Share

   
   
7. WATSON CJ, Zvrskovec J, Merola GP, Gilchrist L, et al
   Splitting schizophrenia: divergent cognitive and educational outcomes revealed by genomic structural equation modelling.
   Mol Psychiatry. 2026 Jan 31. doi: 10.1038/s41380-026-03444.
   

   >> Share

   
   
8. LLORCA-BOFI V, Parellada E, Moren C, Sellgren CM, et al
   Neuroinflammation: an unfortunate term to describe schizophrenia.
   Mol Psychiatry. 2026 Jan 31. doi: 10.1038/s41380-026-03450.
   

   >> Share

   
   
9. MEMETOGLU O, Goyal MS, Chouinard VA, Du F, et al
   Aerobic glycolysis in Schizophrenia: Developmental rescue or energetic breakdown?
   Mol Psychiatry. 2026 Jan 31. doi: 10.1038/s41380-026-03460.
   

   >> Share

   
   

   
   Neuropsychopharmacology

10. ONWORDI EC, Whitehurst T, Shatalina E, Mansur A, et al
    Whole brain grey matter synaptic terminal density, age and intellectual functioning in schizophrenia: an in vivo [(11)C]UCB-J positron emission tomography study.
    Neuropsychopharmacology. 2026 Feb 3. doi: 10.1038/s41386-026-02349.
    

    >> Share

    
    

    
    PLoS Genet

11. ZHANG C, Zhou G, Chen T, Zhao H, et al
    Joint modeling of effect sizes for two correlated traits: Characterizing trait properties to enhance polygenic risk prediction.
    PLoS Genet. 2026;22:e1012026.
    

    >> Share

    
    

    
    PLoS One

12. SMART SE, Fenner E, Humphreys R, Wells A, et al
    Genetics to Improve Outcomes in Schizophrenia (GENios): A within-case molecular genetic study protocol.
    PLoS One. 2026;21:e0340584.
    

    >> Share

    
    

    
    Psychiatry Res

13. VERIM B, Demirlek C, Zorlu N, Erdeniz B, et al
    Transdiagnostic investigation of white matter integrity and cortical thickness in cognitive subgroups within the schizophrenia-bipolar spectrum.
    Psychiatry Res. 2026;358:116964.
    

    >> Share

    
    
14. LEE T, Choi BS, Kim JH
    Cumulative incidence of schizophrenia-spectrum disorders in children and adolescents with neurodevelopmental disorders: A retrospective cohort study.
    Psychiatry Res. 2026;358:116981.
    

    >> Share

    
    

    
    Psychol Med

15. PUJJI SD, Colloca L, Waltz JA
    Placebo and Nocebo Phenomena in Schizophrenia Spectrum Disorders: A Narrative Review on Current Knowledge and Potential Future Directions - CORRIGENDUM.
    Psychol Med. 2026;56:e37.
    

    >> Share

    
    

    
    Schizophr Res

16. ASCHENBRENNER EJ, Voluse AC
    Predicting the prognosis of primary and substance-associated psychoses using urine drug screens: A 5-year retrospective longitudinal study using medical records.
    Schizophr Res. 2026;290:57-64.
    

    >> Share

    
    
17. BAGALI K, Uppinkudru C, Pathak H, Parlikar R, et al
    Aberrant motor cortical plasticity in antipsychotic-resistant schizophrenia: A cross-sectional study using transcranial direct current and magnetic stimulation.
    Schizophr Res. 2026;290:48-56.
    

    >> Share

    
    
18. KRAKOWSKI M, Czobor P
    Disentangling violence in schizophrenia: Interactions between symptom trajectories, conduct disorder, and pharmacotherapy.
    Schizophr Res. 2026;290:42-47.
    

    >> Share

    
    
19. VARDEN GJERDE K, Bartz-Johannessen C, Loberg EM, Steen VM, et al
    Neural and vascular cellular adhesion molecules are associated with cognitive function in patients with schizophrenia-spectrum disorders: A longitudinal study.
    Schizophr Res. 2026;290:34-41.
    

    >> Share

    
    
20. BLACKMAN G, Morrin H, Carstairs C, Fanshawe JB, et al
    Psychopathology distinguishing secondary ("organic") psychoses: A systematic review and meta-analysis.
    Schizophr Res. 2026;289:106-111.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share